Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Neurent Medical secures €25 million growth debt facility from Claret Capital Partners to accelerate commercial expansion.

PRIVATESep 09, 2026•about 3 hours ago

Amount Raised

€25 Million

Round Type

Venture - Series Unknown

OranmoreBiotechnologyHealth Care

Investors

Claret Capital Partners

Description

Neurent Medical has secured a €25 million growth debt financing facility from Claret Capital Partners. This financing will support the company's continued commercial expansion and investment in sales and marketing initiatives. The facility provides significant financial flexibility while allowing Neurent to execute its growth strategy with minimal dilution to shareholders. This follows Neurent Medical's successful €62.5 million Series C financing earlier this year.

Company Information

Company

Neurent Medical

Location

Oranmore, Galway, Ireland

About

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.

Don't miss Neurent Medical's next move

Get an email the moment Neurent Medical raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Neurent Medical's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Neurent Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.